| Literature DB >> 27422115 |
Abderraouf Selmi1,2, Fulvia Vascotto1, Kordula Kautz-Neu3, Özlem Türeci4, Ugur Sahin1,2,5, Esther von Stebut3, Mustafa Diken6,7, Sebastian Kreiter8,9.
Abstract
Intradermal administration of antigen-encoding RNA has entered clinical testing for cancer vaccination. However, insight into the underlying mechanism of RNA uptake, translation and antigen presentation is still limited. Utilizing pharmacologically optimized naked RNA, the dose-response kinetics revealed a rise in reporter signal with increasing RNA amounts and a prolonged RNA translation of reporter protein up to 30 days after intradermal injection. Dendritic cells (DCs) in the dermis were shown to engulf RNA, and the signal arising from the reporter RNA was significantly diminished after DC depletion. Macropinocytosis was relevant for intradermal RNA uptake and translation in vitro and in vivo. By combining intradermal RNA vaccination and inhibition of macropinocytosis, we show that effective priming of antigen-specific CD8(+) T-cells also relies on this uptake mechanism. This report demonstrates that direct antigen translation by dermal DCs after intradermal naked RNA vaccination is relevant for efficient priming of antigen-specific T-cells.Entities:
Keywords: Cancer immunotherapy; Dermal dendritic cell; Intradermal vaccination; Macropinocytosis; Naked RNA; RNA vaccine
Mesh:
Substances:
Year: 2016 PMID: 27422115 DOI: 10.1007/s00262-016-1869-7
Source DB: PubMed Journal: Cancer Immunol Immunother ISSN: 0340-7004 Impact factor: 6.968